(US) /    Tel: (781) 999-4286 / (781) 999-5354
Home > mTOR
Cat.No. Product Name Information Area
T4639 MSDC 0602 MSDC-0602 is an insulin sensitizer potentially for the treatment of diabetes. Non-alcoholic steatohepatitis
T4423 LY303511 hydrochloride LY303511 (NV-128)is a potent mTOR inhibitor
T3514 CZ415 CZ415 is a potent and highly selective mTOR inhibitor.
T3692 GNE 477 GNE-477 is a potent and efficacious dual PI3K/mTOR inhibitor. Others
T3351 CC-223 CC-223 is an orally available mTOR inhibitor with potential antitumor activity. CC-22... Cancer
T3656 PKI-402 PKI-402 is a potent dual pan-PI3K/mTOR inhibitor targeting PI3Kα/β/γ/δ and mTOR with ... Others
T3153 Serabelisib MLN1117 (INK1117) is a p110α/β/γ/δ inhibitor (IC50: 15/4.5/1.9/13.39 μM). Cancer
T3395 Timosaponin AIIInew Timosaponin AIII induces autophagy in HeLa cells followed by apoptotic cell death (IC...
T6510 GDC-0349 GDC-0349 is a potent and selective ATP-competitive inhibitor of mTOR with Ki of 3.8 n... Cancer
T6732 WYE-687 WYE-687 is an ATP-competitive and selective inhibitor of mTOR with IC50 of 7 nM; bloc... Cancer
T6730 WAY-600 WAY-600 is a potent, ATP-competitive and selective inhibitor of mTOR with IC50 of 9 n... Cancer
T6731 WYE-354 WYE-354(IC50=5 nM) is an effective, selective and ATP-competitive mTOR inhibitor. It ... Cancer
T6100 Torin 2 Torin 2(IC50=0.25 nM), a specific and effective mTOR inhibitor, is the 800-fold great... Cancer
T6045 Torin 1 Torin 1 is an effective inhibitor of mTORC1/2 with (IC50: 2 nM/10 nM); has 1000-fold ... Cancer
T6033 Zotarolimus Zotarolimus, an analogue of rapamycin, inhibits FKBP-12 (IC50= 2.8 nM). Cancer
T6030 XL388 XL388 is a highly effective, specifc, ATP-competitive inhibitor of mTOR ( IC50: 9.9 ... Cancer
T2995 Chrysophanic Acid Chrysophanic acid is an EGFR/mTOR pathway inhibitor, which can be found in rhubarb, a... Cancer
T2706 Palomid 529 Palomid 529 has been used in trials studying the treatment of Age-Related Macular Deg... Cancer
T2619 CH5132799 CH5132799 has been used in trials studying the treatment of Solid Tumors. Cancer
T2475 KU0063794 KU-0063794 is a potent and highly specific dual-mTOR inhibitor of mTORC1 and mTORC2. Other
T2434 LY 303511 LY303511, an inactive analogue of LY294002, is a mTOR inhibitor and no inhibition for... Other
T2415 PP121 PP-121 is a multi-targeted inhibitor of PDGFR (IC50: 2 nM), Hck (IC50: 8 nM), mTOR (I... Cancer
T2414 Torkinib PP 242 is a specific and ATP competitive mTOR inhibitor (IC50=8 nM). Other
T2357 GSK-1059615 GSK1059615 has been used in trials studying the treatment of Lymphoma, Solid Tumours,... Cancer
T2235 Dactolisibhot

Dactolisib is an orally bioavailable imidazoquinoline targeting the phosphatidylin...

T2145 Temsirolimus Temsirolimus is a specific mTOR inhibitor, used in the treatment of advanced renal ce... Immunology
T2144 Tacrolimus Tacrolimus is a macrolide isolated from the culture broth of a strain of Streptomyces... Immunology
T2084 ETP46464 ETP-46464 is an effective and specific ATR inhibitor (IC50: 25 nM). Other
T1970 Gedatolisib Gedatolisib is a highly effective dual inhibitor targeting the PI3Kα/γ (IC50: 0.4/5.4... Other
T1961 Vistusertib AZD2014 is an orally bioavailable inhibitor of the mammalian target of rapamycin (mTO... Other